{
    "id": "dbpedia_221_0",
    "rank": 74,
    "data": {
        "url": "https://pubs.acs.org/doi/10.1021/cr400460s",
        "read_more_link": "",
        "language": "en",
        "title": "Metallodrugs in Medicinal Inorganic Chemistry",
        "top_image": "https://pubs.acs.org/cms/10.1021/cr400460s/asset/images/cr400460s.social.jpeg_v03",
        "meta_img": "https://pubs.acs.org/cms/10.1021/cr400460s/asset/images/cr400460s.social.jpeg_v03",
        "images": [
            "https://pubs.acs.org/pb-assets/ux3/pubs-logo-481x82-1523435513963.png",
            "https://pubs.acs.org/cms/10.1021/chreay/asset/16ad6c59-ed16-d6c5-6ed1-ad6c596ed16a/title.png",
            "https://pubs.acs.org/specs/products/achs/releasedAssets/images/loading/loading-018624cffd023ad5641b8e99931a80e6.gif",
            "https://pubs.acs.org/doi/10.1021/specs/products/achs/releasedAssets/images/loading/loader-128b5db1cc3a83761a15cf2e5c9b452d.gif",
            "https://pubs.acs.org/specs/products/achs/releasedAssets/images/access-control/open-access.svg",
            "https://pubs.acs.org/cms/10.1021/cr400460s/asset/images/medium/cr-2013-00460s_0013.gif",
            "https://pubs.acs.org/cms/10.1021/cr400460s/asset/images/medium/cr-2013-00460s_0014.gif",
            "https://pubs.acs.org/cms/10.1021/cr400460s/asset/images/medium/cr-2013-00460s_0015.gif",
            "https://pubs.acs.org/cms/10.1021/cr400460s/asset/images/medium/cr-2013-00460s_0016.gif",
            "https://pubs.acs.org/cms/10.1021/cr400460s/asset/images/medium/cr-2013-00460s_0017.gif",
            "https://pubs.acs.org/cms/10.1021/cr400460s/asset/images/medium/cr-2013-00460s_0018.gif",
            "https://pubs.acs.org/cms/10.1021/cr400460s/asset/images/medium/cr-2013-00460s_0019.gif",
            "https://pubs.acs.org/cms/10.1021/cr400460s/asset/images/medium/cr-2013-00460s_0001.gif",
            "https://pubs.acs.org/cms/10.1021/cr400460s/asset/images/medium/cr-2013-00460s_0002.gif",
            "https://pubs.acs.org/cms/10.1021/cr400460s/asset/images/medium/cr-2013-00460s_0003.gif",
            "https://pubs.acs.org/cms/10.1021/cr400460s/asset/images/medium/cr-2013-00460s_0004.gif",
            "https://pubs.acs.org/cms/10.1021/cr400460s/asset/images/medium/cr-2013-00460s_0005.gif",
            "https://pubs.acs.org/cms/10.1021/cr400460s/asset/images/medium/cr-2013-00460s_0006.gif",
            "https://pubs.acs.org/cms/10.1021/cr400460s/asset/images/medium/cr-2013-00460s_0007.gif",
            "https://pubs.acs.org/cms/10.1021/cr400460s/asset/images/cr-2013-00460s_m001.gif",
            "https://pubs.acs.org/cms/10.1021/cr400460s/asset/images/medium/cr-2013-00460s_0008.gif",
            "https://pubs.acs.org/cms/10.1021/cr400460s/asset/images/medium/cr-2013-00460s_0011.gif",
            "https://pubs.acs.org/cms/10.1021/cr400460s/asset/images/medium/cr-2013-00460s_0012.gif",
            "https://pubs.acs.org/cms/10.1021/chreay.2014.114.issue-8/asset/156dde29-b915-dde2-6b91-6dde296b9156/chreay.2014.114.issue-8.largecover.jpg",
            "https://pubs.acs.org/cms/10.1021/cr400460s/asset/images/medium/cr-2013-00460s_0009.gif",
            "https://pubs.acs.org/cms/10.1021/cr400460s/asset/images/medium/cr-2013-00460s_0013.gif",
            "https://pubs.acs.org/cms/10.1021/cr400460s/asset/images/medium/cr-2013-00460s_0014.gif",
            "https://pubs.acs.org/cms/10.1021/cr400460s/asset/images/medium/cr-2013-00460s_0015.gif",
            "https://pubs.acs.org/cms/10.1021/cr400460s/asset/images/medium/cr-2013-00460s_0016.gif",
            "https://pubs.acs.org/cms/10.1021/cr400460s/asset/images/medium/cr-2013-00460s_0017.gif",
            "https://pubs.acs.org/cms/10.1021/cr400460s/asset/images/medium/cr-2013-00460s_0018.gif",
            "https://pubs.acs.org/cms/10.1021/cr400460s/asset/images/medium/cr-2013-00460s_0019.gif",
            "https://pubs.acs.org/cms/10.1021/cr400460s/asset/images/medium/cr-2013-00460s_0001.gif",
            "https://pubs.acs.org/cms/10.1021/cr400460s/asset/images/medium/cr-2013-00460s_0002.gif",
            "https://pubs.acs.org/cms/10.1021/cr400460s/asset/images/medium/cr-2013-00460s_0003.gif",
            "https://pubs.acs.org/cms/10.1021/cr400460s/asset/images/medium/cr-2013-00460s_0004.gif",
            "https://pubs.acs.org/cms/10.1021/cr400460s/asset/images/medium/cr-2013-00460s_0005.gif",
            "https://pubs.acs.org/cms/10.1021/cr400460s/asset/images/medium/cr-2013-00460s_0006.gif",
            "https://pubs.acs.org/cms/10.1021/cr400460s/asset/images/medium/cr-2013-00460s_0007.gif",
            "https://pubs.acs.org/cms/10.1021/cr400460s/asset/images/medium/cr-2013-00460s_0008.gif",
            "https://pubs.acs.org/cms/10.1021/cr400460s/asset/images/medium/cr-2013-00460s_0011.gif",
            "https://pubs.acs.org/cms/10.1021/cr400460s/asset/images/medium/cr-2013-00460s_0012.gif",
            "https://pubs.acs.org/pb-assets/images/footer_logos/logo-atypon-1525376610217.png",
            "https://pubs.acs.org/pb-assets/images/footer_logos/logo-chorus-1525375622947.png",
            "https://pubs.acs.org/pb-assets/images/footer_logos/logo-cope-1525375622977.png",
            "https://pubs.acs.org/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg",
            "https://pubs.acs.org/pb-assets/images/footer_logos/logo-crossref-1525377362093.png",
            "https://pubs.acs.org/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png",
            "https://pubs.acs.org/pb-assets/images/footer_logos/logo-orcid-1525375623187.png",
            "https://pubs.acs.org/pb-assets/images/footer_logos/logo-portico-1525375623203.png",
            "https://pubs.acs.org/pb-assets/ux3/ACSPubs_logo_tagline_Knockout-1718648850557.svg"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [
            "Katja Dralle Mjos",
            "Chris Orvig",
            "Katja Dralle  Mjos",
            "Chris  Orvig"
        ],
        "publish_date": "2014-01-23T00:00:00",
        "summary": "",
        "meta_description": "",
        "meta_lang": "en",
        "meta_favicon": "/pb-assets/ux3/favicon-1635812676023.ico",
        "meta_site_name": "ACS Publications",
        "canonical_link": "https://pubs.acs.org/doi/10.1021/cr400460s",
        "text": "SPECIAL ISSUE\n\nThis article is part of the 2014 Bioinorganic Enzymology special issue.\n\nK.D.M. thanks the University of British Columbia for a Four-Year Doctoral Fellowship and a Gladys Estella Laird Research Fellowship. C.O. gratefully acknowledges many years of research support from the Natural Sciences and Engineering Research Council (NSERC) of Canada (fellowships, operating and equipment grants), Nordion, and the Canadian Institutes of Health Research (operating grants). C.O. also thanks the Canada Council for the Arts for a Killam Research Fellowship (2011–2013) and the Alexander von Humboldt Foundation for a Research Award, as well as Prof. Dr. Peter Comba and his research group in Heidelberg for hospitality and interesting discussions. We also extend our gratitude to friends and colleagues who participated in fruitful discussions, especially to Dr. Michael J. Abrams.\n\nThis article references 284 other publications.\n\n1\n\nSigel, A.; Sigel, H.; Sigel, R. K. Metal Ions in Biological Systems & Metal Ions in Life Sciences; various books and numerous chapters.\n\n2\n\nThompson, K. H. In Encyclopedia of Inorganic Chemistry; King, R. B., Ed.; John Wiley & Sons Ltd.: Chichester, UK,2011; Chapter 1, pp 1– 10.\n\n3\n\nMagner, L. N. A History of Medicine, 2nd ed.; Taylor & Francis Group, LLC: Boca Raton, FL,2005.\n\n4\n\nOrvig, C.; Abrams, M. J. Chem. Rev.1999, 99, 2201\n\n5\n\nThompson, K. H.; Orvig, C. In Concepts and Models in Bioinorganic Chemistry; Kraatz, H.-B.; Metzler-Nolte, N., Eds.; Wiley-VCH: Weinheim, Germany,2006; Chapter 2, pp 25– 46.\n\n6\n\nThompson, K. H.; Orvig, C. Science2003, 300, 936\n\n7\n\nCanadian Institute for Health Information. Executive Summary: Medical Imaging in Canada 2012; CIHI Publication: Ottawa,2013.\n\n8\n\nEhrlich, P.; Bertheim, A. Ber. Dtsch. Chem. Ges.1912, 45, 756\n\n9\n\nLloyd, N. C.; Morgan, H. W.; Nicholson, B. K.; Ronimus, R. S. Angew. Chem., Int. Ed.2005, 44, 941\n\n10\n\nChast, F. In The Practice of Medicinal Chemistry, 3rd ed.; Wermuth, C. G.; Kubinyi, H., Eds.; Academic Press, Elsevier Ltd.: London, UK,2008, Chapter 1, pp 3– 62.\n\n11\n\nRosenberg, B.; VanCamp, L.; Krigas, T. Nature1965, 205, 698\n\n12\n\nRosenberg, B.; VanCamp, L.; Trosko, J. E.; Mansour, V. H. Nature1969, 222, 385\n\n13\n\nAlderden, R. A.; Hall, M. D.; Hambley, T. W. J. Chem. Educ.2006, 83, 728\n\n14\n\nHambley, T. W. Science2007, 318, 1392\n\n15\n\nMeade, T. Chem. Rev., in this edition.\n\n16\n\nKraatz, H.-B.; Metzler-Nolte, N., Eds. Concepts and Models in Bioinorganic Chemistry; Wiley-VCH: Weinheim, Germany,2006.\n\n17\n\nJones, C. J.; Thornback, J. R. Medicinal Applications of Coordination Chemistry; Royal Society of Chemistry: Cambridge, UK,2007.\n\n18\n\nAlessio, E., Ed. Bioinorganic Medicinal Chemistry, 1st ed.; Wiley-VCH: Weinheim, Germany,2011.\n\n19\n\nDabrowiak, J. C. Metals in Medicine; John Wiley & Sons Ltd.: Chichester, UK,2009.\n\n20\n\nFarrell, N. P., Ed. Uses of Inorganic Chemistry in Medicine, 1st ed.; Royal Society of Chemistry: Cambridge, UK,1999.\n\n21\n\nGielen, M.; Tiekink, E. R. T., Eds. Metallotherapeutic Drugs and Metal-Based Diagnostic Agents: The Use of Metals in Medicine, 1st ed.; John Wiley & Sons Ltd.: Chichester, UK,2005.\n\n22\n\nGaynor, D.; Griffith, D. M. Dalton Trans.2012, 41, 13239\n\n23\n\nCasini, A. J. Inorg. Biochem.2012, 109, 97\n\n24\n\nGuo, Z.; Sadler, P. J. Angew. Chem., Int. Ed.1999, 38, 1512\n\n25\n\nSpecial Edition: Metal Anticancer Compounds. Dalton Trans.2009, 10629– 10936.\n\n26\n\nKomeda, S.; Casini, A. Curr. Top. Med. Chem.2012, 12, 219\n\n27\n\nFarrell, N. P. Curr. Top. Med. Chem.2011, 11, 2623\n\n28\n\nOtt, I. Coord. Chem. Rev.2009, 253, 1670\n\n29\n\nSpecial Edition: Radiopharmaceuticals for Imaging and Therapy. Dalton Trans.2011, 40, 6057– 6300.\n\n30\n\nAnderson, C. J.; Welch, M. J. Chem. Rev.1999, 99, 2219\n\n31\n\nBourassa, M. W.; Miller, L. M. Metallomics2012, 4, 721\n\n32\n\nBanerjee, S.; Raghavan, M.; Pillai, M. R. A.; Ramamoorthy, N. Semin. Nucl. Med.2001, 31, 260\n\n33\n\nCardinal Health. FDA-Approved Radiopharmaceuticals; Rev. 8 No. 6.5.13; http://www.cardinal.com/mps/wcm/connect/1bcdfc80447f1763b29ab77fc4070dc5/7COMPLI9958_FDA-approved_list_082412_v3.pdf?MOD=AJPERES (last accessed October 11,2013) .\n\n34\n\nNunn, A. D. Invest. Radiol.2006, 41, 206\n\n35\n\nJosephson, L.; Rudin, M. J. Nucl. Med.2013, 54, 329\n\n36\n\nBatholomä, M. D.; Louie, A. S.; Valliant, J. F.; Zubieta, J. Chem. Rev.2010, 110, 2903\n\n37\n\nBanerjee, S. R.; Maresca, K. P.; Francesconi, L.; Valliant, J.; Babich, J. W.; Zubieta, J. Nucl. Med. Biol.2005, 32, 1\n\n38\n\nLiu, S.; Edwards, D. S. Chem. Rev.1999, 99, 2235\n\n39\n\nRösch, F. Appl. Radiat. Isot.2013, 76, 24\n\n40\n\nBreeman, W. A. P.; Verbruggen, A. M. Eur. J. Nucl. Med. Mol. Imaging2007, 34, 978\n\n41\n\nEckert & Ziegler GmbH, Berlin; http://www.ezag.com (last accessed July 22,2013) .\n\n42\n\nOctreoPharm Sciences GmbH, Berlin; http://www.octreopharmsciences.com (last accessed July 22,2013) .\n\n43\n\nRösch, F.; Baum, R. P. Dalton Trans.2011, 40, 6104\n\n44\n\nWorld Health Organization. Cancer; Fact sheet No. 297; WHO Press: Geneva,2013.\n\n45\n\nLippert, B., Ed. Cisplatin - Chemistry and Biochemistry of a Leading Anticancer Drug, 1st ed.; Wiley-VCH: Weinheim, Germany,1999.\n\n46\n\nPeyrone, M. Ann. Chem. Pharm.1844, 51, 1\n\n47\n\nRosenberg, B. Interdiscip. Sci. Rev.1978, 3, 134\n\n48\n\nRosenberg, B. Platinum Met. Rev.1971, 15, 42\n\n49\n\nRosenberg, B. Naturwissenschaften1973, 60, 399\n\n50\n\nRosenberg, B.; VanCamp, L.; Krigas, T.Anti-Animal Tumor Method. U.S. Patent Office 4,177,263,1979.\n\n51\n\nEisenstein, R. I.; Resnick, D. S. Nat. Biotechnol.2001, 19, 881\n\n52\n\nBlumenstyk, G. The Chronicles of Higher Education1999, February 12, A39\n\n53\n\nRosenberg, B.; VanCamp, L.; Krigas, T.Anti-Tumor Method. U.S. Patent Office 5,562,925,1996.\n\n54\n\nResearch Corp. Technologies, Inc. Patent Litigation, No. 97-2836 (D.N.J. Oct. 21, 1999), affirmed Research Corp. Techs., Inc. et al. v. Gensia Labs., Inc. et al., 10 Fed. Appx. 856 (Fed. Cir.2001) .\n\n55\n\nReedijk, J. Chem. Rev.1999, 99, 2499\n\n56\n\nWang, D.; Lippard, S. J. Nat. Rev. Drug Discovery2005, 4, 307\n\n57\n\nBerners-Price, S. J.; Appleton, T. G. In Platinum-Based Drugs in Cancer Therapy; Kelland, L.; Farrell, N. P., Eds.; Humana Press Inc.: Totowa, NJ,2000; pp 3– 35.\n\n58\n\nBerners-Price, S. J.; Ronconi, L.; Sadler, P. J. Prog. Nucl. Magn. Reson. Spectrosc.2006, 49, 65\n\n59\n\nCleare, M. J.; Hoeschele, J. D. Bioinorg. Chem.1973, 2, 187\n\n60\n\nCleare, M. J.; Hoeschele, J. D. Platinum Met. Rev.1973, 17, 2\n\n61\n\nCleare, M. J.; Hoeschele, J. D.; Rosenberg, B.; VanCamp, L.Malonato platinum anti-tumor compounds. U.S. Patent Office 4,140,707,1979.\n\n62\n\nKidani, Y.; Noji, M.; Tashiro, T. Gann1980, 71, 637\n\n63\n\nKidani, Y.; Masahide, N.Cytostatic platinum organic complexes. U.S. Patent Office 4,710,577,1987.\n\n64\n\nCharest, G.; Sanche, L.; Fortin, D.; Mathieu, D.; Paquette, B. J. Neurooncol.2013, 115, 365\n\n65\n\nStathopoulos, P. G.; Rigatos, S.; Stathopoulos, J.; Batzios, S. J. Drug Delivery Ther.2012, 2, 106\n\n66\n\nBoulikas, T. Expert Opin. Invest. Drugs2009, 18, 1197\n\n67\n\nRegulon Inc.: Athens; http://www.lipoplatin.com (last accessed October 04,2013) .\n\n68\n\nCarr, J. L.; Tingle, M. D.; McKeage, M. J. Cancer Chemother. Pharmacol.2006, 57, 483\n\n69\n\nHall, M. D.; Hambley, T. W. Coord. Chem. Rev.2002, 232, 49\n\n70\n\nFarrell, N.; Spinelli, S. In Uses of Inorganic Chemistry in Medicine; Farrell, N. P., Ed.; Royal Society of Chemistry: Cambridge, UK,1999, Chapter 8; pp 124– 134.\n\n71\n\nHensing, T. A.; Hanna, N. H.; Gillenwater, H. H.; Camboni, M. G.; Allievi, C.; Socinski, M. A. Anti-Cancer Drugs2006, 17, 697\n\n72\n\nQuiroga, A. G. Curr. Top. Med. Chem.2011, 11, 2613\n\n73\n\nKartalou, M.; Essigmann, J. M. Mutat. Res.2001, 478, 23\n\n74\n\nStewart, D. J. Crit. Rev. Oncol. Hematol.2007, 63, 12\n\n75\n\nKaiser, J. Science2011, 331, 1542\n\n76\n\nCollery, P.; Domingo, J. L.; Keppler, B. K. Anticancer Res.1996, 16, 687\n\n77\n\nNordenberg, J.; Novogrodsky, A.; Beery, E.; Patia, M.; Wasserman, L.; Warshawsky, A. Eur. J. Cancer1990, 26, 905\n\n78\n\nNiiki Pharma, Tampa (FL); http://www.niikipharma.com (last accessed July 22,2013) .\n\n79\n\nBergamo, A.; Sava, G. Dalton Trans.2007, 1267\n\n80\n\nGuidi, F.; Modesti, A.; Landini, I.; Nobili, S.; Mini, E.; Bini, L.; Puglia, M.; Casini, A.; Dyson, P. J.; Gabbiani, C.; Messori, L. J. Inorg. Biochem.2013, 118, 94\n\n81\n\nSava, G.; Bergamo, A.; Dyson, P. J. Dalton Trans.2011, 40, 9069\n\n82\n\nDwyer, F. P.; Gyarfas, E. C.; Roger, W. P.; Koch, J. H. Nature1952, 170, 190\n\n83\n\nHartinger, C. G.; Jakupec, M. A.; Zorbas-Seifried, S.; Groessl, M.; Egger, A.; Berger, W.; Zorbas, H.; Dyson, P. J.; Keppler, B. K. Chem. Biodiversity2008, 5, 2140\n\n84\n\nHartinger, C. G.; Zorbas-Seifried, S.; Jakupec, M. A.; Kynast, B.; Zorbas, H.; Keppler, B. K. J. Inorg. Biochem.2006, 100, 891\n\n85\n\nChen, S. J.; Zhou, G. B.; Zhang, X. W.; Mao, J. H.; de Thé, H.; Chen, Z. Blood2011, 117, 6425\n\n86\n\nLo-Coco, F.ATRA and arsenic trioxide (ATO) versus ATRA and idarubicin (AIDA) for newly diagnosed, non high-risk acute promyelocytic leukemia (APL): Results of the Phase III, prospective, randomoized, intergroup APL0406 study by the Italian-German cooperative groups Gimema-SAL-AMLSG. Paper No. 6; 54th Annual Meeting and Exposition of the American Society of Hematology: Atlanta, GA, December2012.\n\n87\n\nGarnier, N.; Petruccelli, L. A.; Molina, M. F.; Kourelis, M.; Kwan, S.; Diaz, Z.; Schipper, H. M.; Gupta, A.; del Rincon, S. V.; Mann, K. K.; Miller, W. H. Leukemia2013, 27, 2220\n\n88\n\nFinlay, I. G.; Mason, M. D.; Shelley, M. Lancet Oncol.2005, 6, 392\n\n89\n\nRamogida, C. F.; Orvig, C. Chem. Commun.2013, 49, 4720\n\n90\n\nVolkert, W. A.; Goeckeler, W. F.; Ehrhardt, G. J.; Ketring, A. R. J. Nucl. Med.1991, 32, 174\n\n91\n\nSmith, N. A.; Sadler, P. J. Philos. Trans. R. Soc., A2013, 371, 20120519\n\n92\n\nMoore, C. M.; Emberton, M.; Bown, S. G. Lasers Surg. Med.2011, 43, 768\n\n93\n\nPinnacle Biologics, Bannockburn, IL; http://www.photofrin.com (last accessed October 11,2013) .\n\n94\n\nStebabiotech SA, Luxembourg; http://www.stebabiotech.com (last accessed October 11,2013) .\n\n95\n\nGibaud, S.; Jaouen, G. In Medicinal Organometallic Chemistry; Jaouen, G.; Metzler-Nolte, N., Eds.; Springer Verlag, Heidelberg, Germany,2010; Chapter 1, pp 1– 20.\n\n96\n\nPatra, M.; Gasser, G.; Metzler-Nolte, N. Dalton Trans.2012, 41, 6350\n\n97\n\nBreinl, A.; Todd, J. L. Br. Med. J.1907, 1, 132\n\n98\n\nJolliffe, D. M. JRSM1993, 86, 287\n\n99\n\nWorld Health Organization. Trypanosomiasis, Human African (Sleeping Sickness); Fact sheet No. 259; WHO Press: Geneva,2013.\n\n100\n\nGoodwin, L. G. Trans. R. Soc. Trop. Med. Hyg.1995, 89, 339\n\n101\n\nWorld Health Organization. Control of Leishmaniasis; Technical report no. 949; WHO Press: Geneva,2010.\n\n102\n\nOlliaro, P. L.; Guerin, P. J.; Gerstl, S.; Haaskjold, A. A.; Rottingen, J.-A.; Sundar, S. Lancet Infect. Dis.2005, 5, 763\n\n103\n\nSun, H., Ed. Biological Chemistry of Arsenic, Antimony and Bismuth; Wiley: Weinheim, Germany,2010.\n\n104\n\nJanssen, M. J. R.; Hendrikse, L.; de Boer, S. Y.; Bosboom, R.; De Boer, W. A.; Laheij, R. J. F.; Jansen, J. B. M. J. Neth. J. Med.2006, 64, 191\n\n105\n\nMalfertheiner, P.; Bazzoli, F.; Delchier, J.-C.; Celiñski, K.; Giguère, M.; Rivière, M.; Mégraud, F.; the Pylera Study Group Lancet2011, 377, 905\n\n106\n\nDe Boer, W. A.; Van Etten, R. J.; Van De Wouw, B. A.; Schneeberger, P. M.; Van Oijen, A. H.; Jansen, J. B. Aliment. Pharmacol. Ther.2000, 14, 85\n\n107\n\nMicrobion Corp., Bozeman (MT); http://www.microbioncorp.com (last accessed July 22,2013) .\n\n108\n\nEckhardt, S.; Brunetto, P. S.; Gagnon, J.; Priebe, M.; Giese, B.; Fromm, K. M. Chem. Rev.2013, 113, 4708\n\n109\n\nAziz, Z.; Abu, S. F.; Chong, N. J. Burns2012, 38, 307\n\n110\n\nWasiak, J.; Cleland, H.; Campbell, F.; Spinks, A.Dressings for superficial and partial thickness burns. Cochrane Database of Systematic Rev.2013, Issue 3, Article No.: CD002106.\n\n111\n\nGarner, J. P.; Heppell, P. S. J. Burns2005, 31, 539\n\n112\n\nGarner, J. P.; Heppell, P. S. J. Burns2005, 31, 379\n\n113\n\nClinical Trials USA2013; http://www.clinicaltrials.gov.\n\n114\n\nDomarle, O.; Blampain, G.; Agnaniet, H.; Nzadiyabi, T.; Lebibi, J.; Brocard, J.; Maciejewski, L.; Biot, C.; Georges, A. J.; Millet, P. Antimicrob. Agents Chemother.1998, 42, 540\n\n115\n\nBiot, C.; Nosten, F.; Fraisse, L.; Ter-Minassian, D.; Khalife, J.; Dive, D. Parasite2011, 18, 207\n\n116\n\nViamet, Durham (NC); http://www.viamet.com (last accessed July 22,2013) .\n\n117\n\nMajithia, V.; Geraci, S. A. Am. J. Med.2007, 120, 936\n\n118\n\nForestier, J. Lancet1934, 224, 646\n\n119\n\nBerners-Price, S. J. In Bioinorganic Medicinal Chemistry; Alessio, E., Ed.; Wiley-VCH: Weinheim, Germany,2011; Chapter 7, pp 197– 222.\n\n120\n\nBenedek, T. G. J. Hist. Med. Allied Sci.2004, 59, 50\n\n121\n\nGunatilleke, S. S.; Barrios, A. M. J. Inorg. Biochem.2008, 102, 555\n\n122\n\nThe Research Committee of the Empire Rheumatism Council. Ann. Rheum. Dis.1960, 19, 95.\n\n123\n\nMessori, L.; Marcon, G. In Metal Ions in Biological Systems Vol 41: Metal Ions and Their Complexes in Medication; Sigel, A.; Sigel, H., Eds.; Marcel Dekker Inc.: New York,2004; Chapter 9, pp 279– 304.\n\n124\n\nPope, J. E.; Paul, H.; Koehler, B. E. J. Rheumatol.2002, 29, 255\n\n125\n\nLehman, A. J.; Esdaile, J. M.; Klinkhoff, A. V.; Grant, E.; Fitzgerald, A.; Canvin, J.; The METGO Study Group Arthritis & Rheumatism2005, 52, 1360\n\n126\n\nWalz, D. T.; Dimartino, M. J.; Griswold, D. E.; Intoccia, A. P.; Flanagan, T. L. Am. J. Med.1983, 75, 90\n\n127\n\nThakor, A. S.; Jokerst, J.; Zavaleta, C.; Massoud, T. F.; Gambhir, S. S. Nano Lett.2011, 11, 4029\n\n128\n\nNejrup, K.; de Fine Olivarius, N.; Jacobsen, J. L.; Siersma, V. Clin. Rheumatol.2008, 27, 1363\n\n129\n\nLee, S.-M.; Kim, H. J.; Ha, Y.-J.; Park, Y. N.; Lee, S.-K.; Park, Y.-B.; Yoo, K.-H. ACS Nano2013, 7, 50\n\n130\n\nVon Reis, G.; Swensson, A. Acta Med. Scand. (Suppl.)1951, 259, 27\n\n131\n\nBerglöf, F. E. Acta Rheumatol. Scand.1959, 5, 70\n\n132\n\nBessant, R.; Steuer, A.; Rigby, S.; Gumpel, M. Rheumatology2003, 42, 1036\n\n133\n\nSheppeard, H.; Ward, D. J. Rheumatol. Rehabil.1980, 19, 25\n\n134\n\nGoldstein, S.; Czapski, G.; Heller, A. Free Radical Biol. Med.2005, 38, 839\n\n135\n\nWorld Health Organization. Diabetes; Fact sheet No. 312; WHO Press: Geneva,2013.\n\n136\n\nWillsky, G. R.; Goldfine, A. B.; Kostyniak, P. J.; McNeill, J. H.; Yang, L. Q.; Khan, H. R.; Crans, D. C. J. Inorg. Biochem.2001, 85, 33\n\n137\n\nLyonnet, B. M.; Martz Martin, E. Presse Med.1899, 7, 191\n\n138\n\nJosephson, L.; Cantley, L. C. Biochemistry1977, 16, 4572\n\n139\n\nHeyliger, C. E.; Tahiliani, A. G.; McNeill, J. H. Science1985, 227, 1474\n\n140\n\nRehder, D. Coord. Chem. Rev.1999, 182, 297\n\n141\n\nCam, M. C.; Cros, G. H.; Serrano, J. J.; Lazaro, R.; McNeill, J. H. Diabetes Res. Clin. Pract.1993, 20, 111\n\n142\n\nThompson, K. H.; Orvig, C. Coord. Chem. Rev.2001, 219, 1033\n\n143\n\nMcNeill, J. H.; Yuen, V. G.; Hoveyda, H. R.; Orvig, C. J. Med. Chem.1992, 35, 1489\n\n144\n\nMelchior, M.; Rettig, S. J.; Liboiron, B. D.; Thompson, K. H.; Yuen, V. G.; McNeill, J. H.; Orvig, C. Inorg. Chem.2001, 40, 4686\n\n145\n\nThompson, K. H.; Lichter, J.; LeBel, C.; Scaife, M. C.; McNeill, J. H.; Orvig, C. J. Inorg. Biochem.2009, 103, 554\n\n146\n\nThompson, K. H.; Orvig, C. Dalton Trans.2006, 761\n\n147\n\nThompson, K. H.; Orvig, C. J. Inorg. Biochem.2006, 100, 1925\n\n148\n\nCFM-Pharma, B. V.Rotterdam; http://www.cfmpharma.com (last accessed July 22,2013) .\n\n149\n\nWei, Y.-B.; Yang, X.-D. BioMetals2012, 25, 1261\n\n150\n\nMedesis Pharmaceuticals Inc., Montreal; http://www.medesispharma.com (last accessed July 22,2013) .\n\n151\n\nMuñoz, M. C.; Barberà, A.; Domínguez, J.; Fernàndez-Alvarez, J.; Gomis, R.; Guinovart, J. J. Diabetes2001, 50, 131\n\n152\n\nClaret, M.; Corominola, H.; Canals, I.; Saura, J.; Barcelo-Batllori, S.; Guinovart, J. J.; Gomis, R. Endocrinology2005, 146, 4362\n\n153\n\nBarbera, A.; Gomis, R. R.; Prats, N.; Rodriguez-Gil, J. E.; Domingo, M.; Gomis, R.; Guinovart, J. J. Diabetologia2001, 44, 507\n\n154\n\nHanzu, F.; Gomis, R.; Coves, M. J.; Viaplana, J.; Palomo, M.; Andreu, A.; Szpunar, J.; Vidal, J. Diabetes, Obes. Metab.2010, 12, 1013\n\n155\n\nREDOX Pharmaceutical Corp., Greenvale, NY; http://www.redoxpharm.com (last accessed July 22,2013) .\n\n156\n\nSchwartz, J. A.; Lium, E. K.; Silverstein, S. J. J. Virol.2001, 75, 4117\n\n157\n\nLouie, A. Y.; Meade, T. J. Proc. Natl. Acad. Sci. U.S.A.1998, 95, 6663\n\n158\n\nRozenbaum, W.; Dormont, D.; Spire, B.; Vilmer, E.; Gentilini, M.; Griscelli, C.; Montagnier, L.; Barre-Sinoussi, F.; Chermann, J. C. Lancet1985, 325, 450\n\n159\n\nStephan, H.; Kubeil, M.; Emmerling, F.; Müller, C. E. Eur. J. Inorg. Chem.2013, 2013, 1585\n\n160\n\nDan, K.; Miyashita, K.; Seto, Y.; Fujita, H.; Yamase, T. Pharmacol. Res.2002, 46, 357\n\n161\n\nZhang, H.; Qi, Y.; Ding, Y.; Wang, J.; Li, Q.; Zhang, J.; Jiang, Y.; Chi, X.; Li, J.; Niu, J. Bioorg. Med. Chem. Lett.2012, 22, 1664\n\n162\n\nYamase, T. J. Mater. Chem.2005, 15, 4773\n\n163\n\nDe Clercq, E. Nat. Rev. Drug Discovery2003, 2, 581\n\n164\n\nEickhoff, T. C. Vaccine2002, 20, S1\n\n165\n\n“Minamata” Convention Agreed by Nations – Global Mercury Agreement to Lift Health Threats from Lives of Millions World-Wide; http://www.unep.org/newscentre.default.aspx?DocumentID2702&ArticleID9373 (last accessed July 22,2013) and http://www.mercuryconvention.org (last accessed November 08, 2013).\n\n166\n\nThe Micronutrient Initiative, Ottawa; http://www.micronutrient.org (last accessed July 22,2013) .\n\n167\n\nAndersen, O. Mini-Rev. Med. Chem.2004, 4, 11\n\n168\n\nHarrison, O. Vitamin & Supplement Manufacturing in the U.S.; U.S. Industry Report No. 32541d; IBIS World: U.S.,2013.\n\n169\n\nNCT 00001262, Clinical Trials USA 2013; http://www.clinicaltrials.gov (last accessed July 22,2013) .\n\n170\n\nGanite; FDA-approved label,2003.\n\n171\n\nBouillon, R.; Burckhardt, P.; Christiansen, C.; Fleisch, H. A.; Fujita, T.; Gennari, C.; Martin, T. J.; Mazzuoli, G.; Melton, L. J.; Ringe, J. D.; Riis, P.; Peck, W. A.; Samsioe, G.; Shulman, L. E. Am. J. Med.1991, 90, 107\n\n172\n\nJonville-Bera, A.-P.; Autret-Leca, E. Presse Med.2011, 40, 453\n\n173\n\nEuropean Medicines Agency. European Medicines Agency confirms positive benefit-risk balance of Protelos/Osseor, but recommends new contraindications and revised warnings; Press release March 16,2012; http://www.ema.europa.eu.\n\n174\n\nEuropean Medicines Agency. Recommendation to restrict the use of Protelos/Osseor (Strontium ranelate); Press release April 26,2013; http://www.ema.europa.eu.\n\n175\n\nTinker, J. H.; Michenfelder, J. D. Anestesiology1976, 45, 340\n\n176\n\nde C. Pereira, A.; Ford, P. C.; da Silva, R. S.; Bendhack, L. M. Nitric Oxide2011, 24, 192\n\n177\n\nWecksler, S. R.; Mikhailovsky, A.; Korystov, D.; Buller, F.; Kannan, R.; Tan, L.-S.; Ford, P. C. Inorg. Chem.2007, 46, 395\n\n178\n\nSilva, J. J. N.; Osakabe, A. L.; Pavanelli, W. R.; Silva, J. S.; Franco, D. W. Br. J. Pharmacol.2007, 152, 112\n\n179\n\nCameron, B. R.; Darkes, M. C.; Baird, I. R.; Skerlj, R. T.; Santucci, Z. L.; Fricker, S. P. Inorg. Chem.2003, 42, 4102\n\n180\n\nValentine, J. Chem. Rev., in this edition.\n\n181\n\nInagi, R. In Frontiers in Cardiovascular Drug Discovery; Rahman, A.-u.; Choudhary, M. I., Eds.; Bentham Science Publishers Ltd.: Sharjah,2010; Vol. 1, pp 138– 153.\n\n182\n\nBatinić-Haberle, I.; Rebouças, J. S.; Spasojević, I. Antioxid. Redox Signaling2010, 13, 877\n\n183\n\nCuzzocrea, S.; Mazzon, E.; Dugo, L.; Di Paola, R.; Caputi, A. P.; Salvemini, D. FASEB J.2004, 18, 94\n\n184\n\nFriedel, F. C.; Lieb, D.; Ivanović-Burmazović, I. J. Inorg. Biochem.2012, 109, 26\n\n185\n\nWang, Z.-Q.; Porreca, F.; Cuzzocrea, S.; Galen, K.; Lightfood, R.; Masini, E.; Muscoli, C.; Mollace, V.; Ndengele, M.; Ischiropoulos, H.; Salvemini, D. J. Pharmacol. Exp. Ther.2004, 309, 869\n\n186\n\nBirch, N. J. Chem. Rev.1999, 99, 2659\n\n187\n\nPrice, L. H.; Heninger, G. R. N. Engl. J. Med.1994, 331, 591\n\n188\n\nMcCarthy, M. J.; Leckband, S. G.; Kelsoe, J. R. Pharmacogenomics2010, 11, 1439\n\n189\n\nDuffy, A.; Alda, M.; Kutcher, S.; Cavazzoni, P.; Robertson, C.; Grof, E.; Grof, P. J. Clin. Psychiatry2002, 63, 1171\n\n190\n\nGrof, P.; Duffy, A.; Cavazzoni, P.; Grof, E.; Garnham, J.; MacDougall, M.; O’Donovan, C.; Alda, M. J. Clin. Psychiatry2002, 63, 942\n\n191\n\nMalhi, G. S.; Tanious, M.; Das, P.; Coulston, C. M.; Berk, M. CNS Drugs2013, 27, 135\n\n192\n\nHajek, T.; Bauer, M.; Simhandl, C.; Rybakowski, J.; O’Donovan, C.; Pfenning, A.; König, B.; Suwalska, A.; Yucel, K.; Uher, R.; Young, L. T.; MacQueen, G.; Alda, M. Psychol. Med2014, 44, 507\n\n193\n\nPouladi, M. A.; Brillaud, E.; Xie, Y.; Conforti, P.; Graham, R. K.; Ehrnhoefer, D. E.; Franciosi, S.; Zhang, W.; Poucheret, P.; Compte, E.; Maurel, J.-C.; Zuccato, C.; Cattaneo, E.; Neri, C.; Hayden, M. R. Neurobiol. Dis.2012, 48, 282\n\n194\n\nBlindauer, C. Biochem. Mag.2012, 34, 4\n\n195\n\nAndersen, O. Chem. Rev.1999, 99, 2683\n\n196\n\nBickel, H.; Hall, G. E.; Keller-Schierlein, W.; Prelog, V.; Vischer, E.; Wettstein, A. Helv. Chim. Acta1960, 43, 2129\n\n197\n\nCoburn, J. W. Nefrologia (Suppl. 3)1993, 13, 123\n\n198\n\nFlora, S. J.; Flora, G.; Saxena, G.; Mishra, M. Cell Mol. Biol.2007, 53, 26\n\n199\n\nCappellini, M. D.; Cohen, A.; Piga, A.; Bejaoui, M.; Perrotta, S.; Agaoglu, L.; Aydinok, Y.; Kattamis, A.; Kilinc, Y.; Porter, J.; Capra, M.; Galanello, R.; Fattoum, S.; Drelichman, G.; Magnano, C.; Verissimo, M.; Athanassiou-Metaxa, M.; Giardina, P.; Kourakli-Symeonidis, A.; Janka-Schaub, G.; Coates, T.; Vermylen, C.; Olivieri, N.; Thuret, I.; Opitz, H.; Ressayre-Djaffer, C.; Marks, P.; Alberti, D. Blood2006, 107, 3455\n\n200\n\nGiardini, C. Curr. Opin. Hematol.1997, 4, 79\n\n201\n\nCohen, A. R.; Galanello, R.; Piga, A.; De Sanctis, V.; Tricta, F. Blood2003, 102, 1583\n\n202\n\nde Bie, P.; Muller, P.; Wijmenga, C.; Klomp, L. W. J. J. Med. Genet.2007, 44, 673\n\n203\n\nAlvarez, H. M.; Xue, Y.; Robinson, C. D.; Canalizo-Hernández, M. A.; Marvin, R. G.; Kelly, R. A.; Mondragón, A.; Penner-Hahn, J. E.; O’Halloran, T. V. Science2010, 327, 331\n\n204\n\nBrewer, G. J.; Hedera, P.; Kluin, K. J.; Carlson, M.; Askari, F.; Dick, R. B.; Sitterly, J.; Fink, J. K. Arch. Neurol.2003, 60, 379\n\n205\n\nWorld Health Organization. Dementia; Fact sheet No. 362; WHO Press: Geneva,2012.\n\n206\n\nLesage, S.; Brice, A. Hum. Mol. Genet.2009, 18, R48\n\n207\n\nScott, L. E.; Orvig, C. Chem. Rev.2009, 109, 4885\n\n208\n\nTelpoukhovskaia, M. A.; Orvig, C. Chem. Soc. Rev.2013, 42, 1836\n\n209\n\nBadrick, A. C.; Jones, C. E. Curr. Top. Med. Chem.2011, 11, 543\n\n210\n\nSharpe, P. C.; Richardson, D. R.; Kalinowski, D. S.; Bernhardt, P. V. Curr. Top. Med. Chem.2011, 11, 591\n\n211\n\nBareggi, S. R.; Cornelli, U. CNS Neurosci. Ther.2012, 18, 41\n\n212\n\nRitchie, C. W.; Bush, A. I.; Mackinnon, A.; Macfarlane, S.; Mastwyk, M.; MacGregor, L.; Kiers, L.; Cherny, R.; Li, Q.-X.; Tammer, A.; Carrington, D.; Mavros, C.; Volitakis, I.; Xilinas, M.; Ames, D.; Davis, S.; Beyreuther, K.; Tanzi, R. E.; Masters, C. L. Arch. Neurol.2003, 60, 1685\n\n213\n\nLannfelt, L.; Blennow, K.; Zetterberg, H.; Batsman, S.; Ames, D.; Harrison, J.; Masters, C. L.; Targum, S.; Bush, A. I.; Murdoch, R.; Wilson, J.; Ritchie, C. W. Lancet Neurol.2008, 7, 779\n\n214\n\nPrana Biotechnology Limited, Parkville (VIC); http://www.pranabio.com (last accessed July 22,2013) .\n\n215\n\nRelkin, N. R. Lancet Neurol.2008, 7, 762\n\n216\n\nMoe, S.; Drüeke, T.; Cunningham, J.; Goodman, W.; Martin, K.; Olgaard, K.; Ott, S.; Sprague, S.; Lameire, N. Kidney Int.2006, 69, 1945\n\n217\n\nBover, J.; Andrés, E.; Lloret, M. J.; Aguilar, A.; Ballarín, J. Blood Purif.2009, 27, 369\n\n218\n\nNational Kidney Foundation. K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. Am. J. Kidney Dis. (Supp. 3)2003, 42, S1; http://www.kidney.org/professionals/kdoqi/guidelines_bone/index.htm (last accessed July 22, 2013).\n\n219\n\nMehrotra, R.; Martin, K. J.; Fishbane, S.; Sprague, S. M.; Zeig, S.; Anger, M. Clin. J. Am. Soc. Nephrol.2008, 3, 1437\n\n220\n\nAwah, N. W.; Kaneko, A. Clin. Infect. Dis.2012, 54, 1145\n\n221\n\nMenendez, C.; Kahigwa, E.; Kahigwa, E.; Hirt, R.; Vounatsou, P.; Aponte, J. J.; Font, F.; Acosta, C. J.; Schellenberg, D. M.; Galindo, C. M.; Kimario, J.; Urassa, H.; Brabin, B.; Smith, T. A.; Kitua, A. Y.; Tanner, M.; Alonso, P. L. Lancet1997, 350, 844\n\n222\n\nSmith, H. J.; Meremikwu, M. M.Iron-chelating agents for treating malaria. Cochrane Database of Systematic Rev.2003, Issue 2, Article No.: CD001474.\n\n223\n\nDriggers, E. M.; Hale, S. P.; Lee, J.; Terret, N. K. Nat. Rev. Drug Discovery2008, 7, 608\n\n224\n\nDe Clercq, E. Pharmacol. Therap.2010, 128, 509\n\n225\n\nMann, B. S.; Johnson, J. R.; Cohen, M. H.; Justice, R.; Pazdur, R. The Oncologist2007, 12, 1247\n\n226\n\nSun, H.; Chai, Z.-F. Annu. Rep. Prog. Chem., Sect. A: Inorg. Chem.2010, 106, 20\n\n227\n\nMounicou, S.; Szpunar, J.; Lobinski, R. Chem. Soc. Rev.2009, 38, 1119\n\n228\n\nSzpunar, J. Analyst2005, 130, 442\n\n229\n\nHarford, C.; Sarkar, B. Acc. Chem. Res.1997, 30, 123\n\n230\n\nSankararamakrishnan, R.; Verma, S.; Kumar, S. Proteins2005, 58, 211\n\n231\n\nParkin, G. Chem. Rev., in this edition.\n\n232\n\nSolomon, E. I. Chem. Rev., in this edition.\n\n233\n\nde Almeida, A.; Oliveira, B. L.; Correia, J. D. G.; Soveral, G.; Casini, A. Coord. Chem. Rev.2013, 257, 2689\n\n234\n\nBarry, N. P. E.; Sadler, P. J. Chem. Commun.2013, 49, 5106\n\n235\n\nBarry, N. P. E.; Sadler, P. J. ACS Nano2013, 7, 5654\n\n236\n\nSava, G.; Jaouen, G.; Hillard, E. A.; Bergamo, A. Dalton Trans.2012, 41, 8226\n\n237\n\nNavarro, M.; Gabbiani, C.; Messori, L.; Gambino, D. Drug Discovery Today2010, 15, 1070\n\n238\n\nBerthron, G., Ed. Handbook of Metal-Ligand Interactions in Biological Fluids; Marcel Dekker Inc.: New York,1995; Vols. 1–2.\n\n239\n\nGroessl, M.; Dyson, P. J. Curr. Top. Med. Chem.2011, 11, 2632\n\n240\n\nParker, L. J.; Ascher, D. B.; Gao, C.; Miles, L. A.; Harris, H. H.; Parker, M. W. J. Inorg. Biochem.2012, 115, 138\n\n241\n\nPetković, M.; Kamčeva, T. Metallomics2011, 3, 550\n\n242\n\nMeermann, B.; Sperling, M. Anal. Bioanal. Chem.2012, 403, 1501\n\n243\n\nBytzek, A. K.; Hartinger, C. G. Electrophoresis2012, 33, 622\n\n244\n\nRodríguez-Rodríguez, C.; Telpoukhovskaia, M.; Orvig, C. Coord. Chem. Rev.2012, 256, 2308\n\n245\n\nWong, G. T.Alzheimer Research Forum; August 28,2007; http://www.alzforum.org/new/detail.asp?id=1647 (last accessed July 22,2013) .\n\n246\n\nMeggers, E. Curr. Opin. Chem. Biol.2007, 11, 287\n\n247\n\nStorr, T.; Thompson, K. H.; Orvig, C. Chem. Soc. Rev.2006, 35, 534\n\n248\n\nMeggers, E. Chem. Commun.2009, 1001\n\n249\n\nHuang, R.; Wallqvist, A.; Covell, D. G. Biochem. Pharmacol.2005, 69, 1009\n\n250\n\nSiegbahn, P. Chem. Rev., in this edition.\n\n251\n\nMeggers, E.; Atilla-Gokcumen, G. E.; Gründler, K.; Frias, C.; Prokop, A. Dalton Trans.2009, 10882\n\n252\n\nBullock, A. N.; Russo, S.; Amos, A.; Pagano, N.; Bregman, H.; Debreczeni, J. É.; Lee, W. H.; von Delft, F.; Meggers, E.; Knapp, S. PLoS One2009, 4, e7112\n\n253\n\nSüss-Fink, G. Dalton Trans.2010, 39, 1673\n\n254\n\nAird, R. E.; Cummings, J.; Ritchie, A. A.; Muir, M.; Morris, R. E.; Chen, H.; Sadler, P. J.; Jodrell, D. I. Br. J. Cancer2002, 86, 1652\n\n255\n\nBergamo, A.; Masi, A.; Peacock, A. F. A.; Habtemariam, A.; Sadler, P. J.; Sava, G. J. Inorg. Biochem.2010, 104, 79\n\n256\n\nScolaro, C.; Bergamo, A.; Brescacin, L.; Delfino, R.; Cocchietto, M.; Laurenczy, G.; Geldbach, T. J.; Sava, G.; Dyson, P. J. J. Med. Chem.2005, 48, 4161\n\n257\n\nRatanaphan, A.; Temboot, P.; Dyson, P. J. Chem. Biodiversity2010, 7, 1290\n\n258\n\nRomero-Canelón, I.; Sadler, P. J. Inorg. Chem.2013, 52, 12276\n\n259\n\nCasini, A.; Reedijk, J. Chem. Sci.2012, 3, 3135\n\n260\n\nHarris, W. R.; Sheldon, J. Inorg. Chem.1990, 29, 119\n\n261\n\nCampbell, R. F.; Chasteen, N. D. J. Biol. Chem.1977, 252, 5996\n\n262\n\nZak, O.; Aisen, P. Biochemistry1988, 27, 1075\n\n263\n\nAlbert, A. Selective Toxicity - The Physico-chemical Basis of Therapy, 7th ed.; Chaoman and Hall: London, UK; New York,1985.\n\n264\n\nHuttunen, K. M.; Rautio, J. Curr. Top. Med. Chem.2011, 11, 2265\n\n265\n\nSharma, V.; Piwnica-Worms, D. Chem. Rev.1999, 99, 2545\n\n266\n\nSalas, P. F.; Herrmann, C.; Orvig, C. Chem. Rev.2013, 113, 3450\n\n267\n\nGasser, G.; Ott, I.; Metzler-Nolte, N. J. Med. Chem.2011, 54, 3\n\n268\n\nWyatt, P. G.; Gilbert, I. H.; Read, K. D.; Fairlamb, A. H. Curr. Top. Med. Chem.2011, 11, 1275\n\n269\n\nCollins, I.; Workman, P. Nat. Chem. Biol.2006, 2, 689\n\n270\n\nGunaratna, C. Curr. Sep. Drug Dev.2000, 19, 17\n\n271\n\nLipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J. Adv. Drug Delivery Rev.2001, 46, 3\n\n272\n\nFricker, S. P. Dalton Trans.2007, 4903\n\n273\n\nBaes, C. J.; Mesmer, R. E. The Hydrolysis of Cations; Robert F. Krieger Publishing Company: Malabar, FL,1986.\n\n274\n\nHarris, W. R.; Carrano, C. J.; Cooper, S. R.; Sofen, S. R.; Avdeef, A. E.; McArdle, J. V.; Raymond, K. N. J. Am. Chem. Soc.1979, 101, 6097\n\n275\n\nPritchard, J. F.; Jurima-Romet, M.; Reimer, M. L. J.; Mortimer, E.; Rolfe, B.; Cayen, M. N. Nat. Rev. Drug Discovery2003, 2, 542\n\n276\n\nSanchez-Cano, C.; Hannon, M. J. Dalton Trans.2009, 10702\n\n277\n\nJohnstone, T. C.; Kulak, N.; Pridgen, E. M.; Farokhzad, O. C.; Langer, R.; Lippard, S. J. ACS Nano2013, 7, 5675\n\n278\n\nStathopoulos, G. P.; Antoniou, D.; Dimitroulis, J.; Stathopoulous, J.; Marosis, K.; Michalopoulou, P. Cancer Chemother. Pharmacol.2011, 68, 945\n\n279\n\nStathopoulous, G. P.; Boulikas, T.; Kourvetaris, A.; Stathopoulous, J. Anticancer Res.2006, 26, 1489\n\n280\n\nArrowsmith, J.; Miller, P. Nat. Rev. Drug Discovery2013, 12, 569\n\n281\n\nVincent, J. In The Bioinorganic Chemistry of Chromium; Vincent, J., Ed.; John Wiley & Sons Ltd.: Chichester, UK,2013; Chapter 2, pp 7– 30.\n\n282\n\nFunctional metal complexes that bind to biomolecules. Action CM1105 (2012–2016); http://www.cm1105.eu (last accessed July 22,2013) .\n\n283\n\nTheophrast von Hohenheim, P. In Sieben Defensiones (Antwort auf etliche Verunglimpfungen seiner Misgönner); Sudhoff, K., Ed.; Klassiker der Medizin; Verlag von Johann Ambrosius Barth: Leipzig, Germany,1915.\n\n284\n\nBertrand, G. 8th Int. Congr. Appl. Chem.1912, 28, 30"
    }
}